Chairing the Junior League’s Holiday Mart and taking part in FBI training were just some of the side trips on Allison Karns’ road to becoming one of the key legal minds in the Holcomb administration.
The youngest person ever to direct the Indiana Office of Medicaid Policy and Planning, Jeff Wells went on to co-found and run a company devoted to onsite and near-site medical clinics. Its first clinic opened in 2010, and the company now has 30 locations in five states.
Paying these fees causes many families to sacrifice extra-curricular experiences and sports participation for their children or even curtail family vacations.
Intense demand for chicken wings from a growing roster of retailers drove up prices last year. Restaurateurs like Buffalo Wild Wings are relieved that supply has normalized again, just in time for the Super Bowl.
Moontown Brewing Co. has transformed the former home for secondary education into a taproom with 15 brewing barrels. A full restaurant is in the works.
Home sales of $1 million or more in the Indianapolis area have skyrocketed 143 percent since 2012. Last year, nearly 150 such homes were sold, compared to only 61 five years ago.
With the help of friends and family who wrote letters in his support, the first defendant avoided prison time. The second, who's also casting himself as a model citizen who exercised bad judgment, is hoping for the same outcome.
Taylor Jennings doesn’t want people to do their business at home. Instead, he wants them to go to an OutHouse, a co-working space that also serves as a furniture showroom for Jennings Commercial Interiors.
An Indiana House committee on Wednesday advanced a bill that the payday loan industry says would create a longer-term, higher-value loan for people who have such bad credit scores that they can’t be helped by regular banks.
A proposal to reverse the ban that has precluded Marion County and surrounding suburbs from building or acquiring a light-rail mass-transit project passed an Indiana House committee Wednesday.
More deals could be on the horizon as dozens of companies—including local powerhouses such as Simon, Eli Lilly and Anthem—game out what Amazon’s huge ambitions could mean for their bottom lines.
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
